The current valuation score of Barinthus Biotherapeutics PLC is 8.32, ranking 145 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.50, which is -4508.57% below the recent high of 21.96 and -1145.12% above the recent low of -6.20.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.